期刊文献+

3D-CRT联合DC-CIK细胞治疗高原地区复发性小细胞肺癌的疗效观察 被引量:4

Observation on effect of 3D-CRT combined with DC-CIK cell in treatment of recurrent smell cell carcinoma in high altitude regions
下载PDF
导出
摘要 目的探讨三维适型放疗(3D-CRT)联合树突状细胞-细胞因子诱导的杀伤细胞(DC-CIK)回输治疗高原地区复发性小细胞肺癌(SCLC)的临床疗效,以及对血管内皮生长因子(VEGF)、神经元特异性烯醇化酶(NSE)的影响。方法选取2012年5月至2014年4月青海省第五人民医院肿瘤放疗科收治的复发性SCLC患者85例,按随机数字表法分为对照组(41例)与观察组(44例),分别给予单纯3D-CRT治疗,3D-CRT联合DC-CIK细胞治疗,比较两组的疗效、不良反应发生率、治疗前后VEGF及NSE水平,并观察治疗前后两组各项肝、肾功能指标变化。结果观察组的有效率(65.9%)及疾病控制率(79.5%)均高于对照组,差异均有统计学意义(P<0.05)。两组治疗4、8周后,血清VEGF、NSE水平及疼痛评分均下降,差异均有统计学意义(P<0.05);治疗8周后,观察组VEGF、NSE水平及疼痛评分均低于对照组,差异均有统计学意义(P<0.05)。两组各项不良反应发生率比较,差异均无统计学意义(P>0.05)。两组治疗前及治疗后各项肝、肾功能指标水平比较,差异均无统计学意义(P>0.05)。结论 3D-CRT联合DC-CIK细胞生物治疗高原地区复发性SCLC的疗效更明显,且对放(化)疗不良反应及肝、肾功能无明显影响。 Objective To investigate the effect of 3-dimensonal conformal radiotherapy(3D-CRT) combined with dendritic cell cytokine induced kill (DC-CIK) cell in the treatment of recurrent small cell lung carcinoma(SCLC) in high altitude regions,and its influence on VEGF and NSE. Methods Eighty-five patients with recurrent SCLC in the tumor radiotherapy department of the Qinghai Provincial Fifth People' s Hospital from May 2012 tO April 2014 were selected and divided into the control group(41 cases) and observation group(44 cases) according to the random number table. The two groups were respectively treated by 3D-CRT treat- ment and 3IYCRT combined with DC-CIK treatment cell. The curative effect, incidence rate of adverse reactions,levels of VEGF and NSE,changes of liver and renal function indexes in the two groups were compared before and after treatment. Results The ef- fective rate and sickness control rate of the observation group were 65.9 ~ and 79.5 ~ respectively, which were higher than those in the control group,and the differences were statistically significant(P〈0.05). The levels of serum EGF and NSE,and pain score at 4,8 weeks after treatment were decreased,the differences were statistically significant(P〈0.05). The levels of VEGF and NSE, and pain score at 8 weeks after treatment in the observation group were lower than those in the control group,the differences were statistically significant(P〈0.05). The incidence rate of adverse reactions in the two groups had no statistically significant differ- ences after treatment(P〈0.05). The levels of liver and renal function indexes had no statistically significant differences between before and after treatment(P〈0.05). Conclusion 3D-CRT combined with DC-CIK cell in the treatment of recurrent SCLC in high altitude regions has more obvious curative effect,moreover has no obvious influence on radiotherapeutic adverse reactions,and liver and renal functions.
出处 《重庆医学》 CAS 北大核心 2016年第19期2652-2654,2657,共4页 Chongqing medicine
关键词 小细胞肺癌 三维适形放疗 树突状细胞 细胞因子诱导的杀伤细胞 smell cell carcinoma 3-d conformal radiotherapy dendritic cell cytokine induced kill cell
  • 相关文献

参考文献14

  • 1Bettington CS, Tripcony L, Bryant G. A retrospective a- nalysis of survival outcomes for two different radiothera py fractionation schedules given in the same overall time for limited stage small cell lung cancer[J]. J Med Imaging Radiat Oncol,2013,57(1) : 105-112.
  • 2Alevizakos M, Kaltsas S, Syrigos KN. The VEGF path way in lung cancerFJ~. Cancer Chemother Pharmacol, 2013,72(6) :1169-1181.
  • 3Tanaka F,Ishikawa S, Yanagihara K, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer[J~. Cancer Res,2002,62(23) :7124-7129.
  • 4Yamaguehi Y, Ohshita A, Kawabuchi Y, et al. Adoptive immunotherapy of cancer using activatedautologous lymphocytes-current status andnew strategies EJ~. Hum Ce11,2003,16(4) :183-189.
  • 5王琦,任秀宝,蒋敬庭.肺癌免疫细胞治疗临床转化的研究进展[J].中国肿瘤生物治疗杂志,2015,22(3):375-380. 被引量:11
  • 6韩锁利.DC-CIK联合EP方案治疗广泛期小细胞肺癌疗效观察[J].临床肺科杂志,2014,19(10):1923-1924. 被引量:3
  • 7Colaco RJ, Huh S, Nichols RC, et al. Dosimetric rationale and early experience at UFPT1 of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer [J]. Aeta Oncol,2013,52(3) :506-513.
  • 8Andersen M,Kristjansen PE, Hansen HH. Seconded line chemotherapy in small cell lung cancer[J]. Cancer.Treat Rev, 1990,17(4) :427-436.
  • 9Kelly K. New chemotherapy agents for small cell lung cancer[J]. Chest,2000,117(4 Suppl 1) : 156S-162S.
  • 10Zhan P,Wang J,Lv XJ,et al. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysisEJ~. J Tho- rac Oncol,2009,4(9) :1094-1103.

二级参考文献75

  • 1Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量:83
  • 2张青云,徐建军,王雅明.人神经元特异性烯醇化酶在肿瘤细胞系中的表达检测及意义[J].中华检验医学杂志,2005,28(7):728-731. 被引量:12
  • 3郑秋红,郑天荣,谢云青,陈蓉明,龚福生,汪相如.树突状细胞对自体CIK细胞体外杀伤肺腺癌细胞影响的研究[J].肿瘤防治杂志,2005,12(16):1237-1240. 被引量:14
  • 4韩宝惠,钟华,范小红,冯光丽,李榕,龚乐罗,储天晴,张伟,金波,施春雷,赵怡卓,沙惠芳,董强刚,廖美琳.CEA多肽致敏的树突状细胞(DC)治疗晚期非小细胞肺癌临床初步研究[J].中国肺癌杂志,2006,9(4):340-344. 被引量:3
  • 5Steak M, Oenings A, Eymanne E, et al.Develepment of a new automated enzyme immunoassay for the determination of neuro-speciflc enolapse [J].Antieaneer Res, 1999,19(4A) : 2759-2762.
  • 6Pujol J L,Quantin X,Jacot W,et al.Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer [J]. Lung Cancer, 2003,39(2) : 131-138.
  • 7Ruibal A,Nuhez M I,Rodriguez J,et al.Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung [J].Biol Markers, 2003,18 (3) : 188-194.
  • 8He P,Naka T,Serada S,et al.Proteomics-based identification ofalpha-enolase as a tumor antigen in non-small lung cancer[J].Cancer Sci, 2007,98(8) : 1234-1240.
  • 9Zych J,Sztunnowicz M, Sakowicz A,et al.Neuron-specific eno-lase (NSE) serum level as a prognostic factor in non small cell lung cancer[J]. Preumonol Alergol Pol, 2002,70 (5-6) : 278-283.
  • 10Muraki M,Tohda Y,Lwanga T,et al.Assessment of serum CYFR A21 - 1 in lung caneer[J].Cancer, 1996,77 ( 7 ) : 1274-1277.

共引文献37

同被引文献64

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部